| Identification | Back Directory | [Name]
1,4,7,10,15-Pentaazacycloeicos-12-ene-16-carboxamide, 9-(4-aminobutyl)-3-[(4-benzoylphenyl)methyl]-6-(cyclohexylmethyl)-2,5,8,11,14-pentaoxo-, (3R,6S,9S,12E,16S)-, 2,2,2-trifluoroacetate (1:1) | [CAS]
1774353-12-6 | [Synonyms]
IDE-IN-6bK
IDE-inhibitor-6bK
IDE inhibitor 6bK
(3R,6S,9S,12E,16S)-9-(4-Aminobutyl)-3-[(4-benzoylphenyl)methyl]-6-(cyclohexylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,15-pentaazacycloeicos-12-ene-16-carboxamide
1,4,7,10,15-Pentaazacycloeicos-12-ene-16-carboxamide, 9-(4-aminobutyl)-3-[(4-benzoylphenyl)methyl]-6-(cyclohexylmethyl)-2,5,8,11,14-pentaoxo-, (3R,6S,9S,12E,16S)-, 2,2,2-trifluoroacetate (1:1) | [Molecular Formula]
C43H56F3N7O9 | [MDL Number]
MFCD30182289 | [MOL File]
1774353-12-6.mol | [Molecular Weight]
871.96 |
| Hazard Information | Back Directory | [Uses]
(3R,6S,9S,12E,16S)-9-(4-Aminobutyl)-3-[(4-benzoylphenyl)methyl]-6-(cyclohexylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,15-pentaazacycloeicos-12-ene-16-carboxamide has been identified as an insulin-degrading enzyme (IDE) inhibitor. |
|
|